20 Nov Hydrochlorothiazide use and the risk of skin cancer (Q19-05)
Posted at 16:40h
in
Hydrochlorothiazide use and the risk of skin cancer (Q19-05)
Q19-05
Overview
Background
- Hydrochlorothiazide (HCTZ), a thiazide diuretic, is among the most widely used antihypertensive drugs.
- HCTZ has been shown to have photosensitizing properties and recent observational studies have associated its use with an increased risk of non-melanoma and melanoma skin cancer.
Aims of the study
- The study objective is to determine whether the use of HCTZ is associated with an increased risk of non-melanoma and melanoma skin cancer compared with the use of angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers (CCB).